TAZORAC
TAZORAC
Discontinued
DIN Number
02230784
Drug Class
Human
Market Date
Apr 10, 1997
Company
HC
Allergan, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02230784
AIG Number0133047001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D05AX05 TAZAROTENE
Product Specifications
Dosage FormGel
Route of AdministrationTopical
AHFS Classification84:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TAZAROTENEActive
Strength: 0.05 %
Monograph: TAZAROTENE